Liposomal curcumin inhibits cigarette smoke induced senescence and inflammation in human bronchial epithelial cells

• Published in: Pathology, research and practice Vol. 260; p. 155423
• Main Authors: Kokkinis, Sofia, De Rubis, Gabriele, Paudel, Keshav Raj, Patel, Vyoma K., Yeung, Stewart, Jessamine, Victoria, MacLoughlin, Ronan, Hansbro, Philip M., Oliver, Brian, Dua, Kamal
• Format: Journal Article
• Language: English
• Published: Germany Elsevier GmbH 01.08.2024
• Subjects: Chronic Obstructive Pulmonary Disease; Curcumin; Liposomes; Nanoparticles; Phytoceuticals; PlexoZome; Nanoparticles; Phytoceuticals; Chronic Obstructive Pulmonary Disease; Curcumin; Liposomes; PlexoZome
• ISSN: 0344-0338; 1618-0631; 1618-0631
• DOI: 10.1016/j.prp.2024.155423

Curcumin, the principal curcuminoid of turmeric (Curcuma longa extract), is very well known for its multiple biological therapeutic activities, particularly its anti-inflammatory and antioxidant potential. However, due to its low water solubility, it exhibits poor bioavailability. In order to overcome this problem, in the current study, we have employed liposomal technology to encapsulate curcumin with the aim of enhancing its therapeutic efficacy. The curcumin-loaded liposomes (PlexoZome®) were tested on a cigarette smoke extract-induced Chronic Obstructive Pulmonary Disease (COPD) in vitro model using minimally immortalized human bronchial epithelial cells (BCiNS1.1). The anti-senescence and anti-inflammatory properties of PlexoZome® were explored. 5 µM PlexoZome® curcumin demonstrated anti-senescent activity by decrease in X-gal positive cells, and reduction in the expression of p16 and p21 in immunofluorescence staining. Moreover, PlexoZome® curcumin also demonstrated a reduction in proteins related to senescence (osteopontin, FGF basic and uPAR) and inflammation (GM-CSF, EGF and ST2). Overall, the results clearly demonstrate the therapeutic potential of curcumin encapsulated liposomes in managing CSE induced COPD, providing a new direction to respiratory clinics.